Pediatrics

3/31/22 → 12/31/23

Project: Other project

A Phase IIb, Randomized, Observer-Blind study to Describe the Safety, Tolerability, and Immunogenicity of MenABCWY Administered on Different Dosing Schedules in Healthy Adolescents

2/14/22 → 2/13/27

Project: Other project

A Phase 3, Randomized, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age

2/11/22 → 2/10/27

Project: Other project

A Phase 1/2, First-Time-in Human (FTiH), randomized, observer-blind, placebo-controlled, dose escalation study to assess safety, reactogenicity and immunogenicity of a candidate cytomegalovirus (CMV) vaccine comprising recombinant protein and adjuvant wh

11/12/21 → 11/11/26

Project: Other project

A Multicenter, Open-Label, Pharmacokinetic and Safety Study of Baricitinib in Pediatric Patients from 1 Year to Less than 18 Years Old Hospitalized with COVID-19

Aigbivbalu, L.

10/1/21 → 9/30/26

Project: Other project

A Phase 1/2 Study of Delayed Heterologous SARS-CoV-2 Vaccine Dosing (Boost) after Receipt of EUA Vaccines

7/14/21 → 11/30/22

Project: Other project

PHASE 1, OPEN-LABEL DOSE-FINDING STUDY TO EVALUATE SAFETY, TOLERABILITY, AND IMMUNOGENICITY AND PHASE 2/3 PLACEBO-CONTROLLED, OBSERVER-BLINDED SAFETY, TOLERABILITY, AND IMMUNOGENICITY STUDY OF A SARS-COV-2 RNA VACCINE CANDIDATE AGAINST COVID-19 IN HEALTH

3/29/21 → 3/28/26

Project: Other project

A Phase 3 Randomized, Observer-blind Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Lyophilized Formulation of the Vaccine Candidate BNT162b2 Against COVID-19 in Healthy Adults 18 through 55 years of Age.

3/11/21 → 3/10/25

Project: Other project

Re: A Phase 3 Randomized, Observer-blind Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Lyophilized Formulation of the Vaccine Candidate BNT162b2 Against COVID-19 in Healthy Adults 18 through 55 years of Age.

3/11/21 → 3/10/25

Project: Other project

A Phase 2b/3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MK-1654 in Healthy Pre-Term and Full-Term Infants

1/29/21 → 1/28/26

Project: Other project

A PHASE 3, SINGLE-ARM TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF A 20-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN HEALTHY CHILDREN 15 MONTHS THROUGH 17 YEARS OF AGE

1/4/21 → 1/3/23

Project: Other project

A Phase 3 International, Multicenter, Open-label Study to Evaluate the Safety and Immunogenicity of 9vHPV Vaccine Administered as 2-dose Regimen with Extended Dosing Intervals in 9- to 14-Year Old Boys and Girls Compared with a Standard 3-dose Regimen

12/22/20 → 12/21/25

Project: Other project

Innate Inhibitory Activity and Anti-SARS-CoV-2 Antibodies in Human Milk

11/20/20 → 11/19/23

Project: Other project

Vaccine and Treatment Evaluation Units (VTEU)- COVID Supplement

7/13/20 → 11/30/22

Project: Other project

Vaccine and Treatment Evaluation Units (VTEU)- COVID Supplement

BAYLOR COLLEGE OF MEDICINE

7/13/20 → 11/30/22

Project: Other project

A Phase 1/2, Placebo-Controlled, Randomized, Observer-Blind, Dose Finding Study To Describe the Safety, Tolerability, Immunogenicity, and Potential Efficacy of SARS-CoV-2 RNA Vaccine Candidates against COVID 19 in Healthy Adults

Pfizer, Inc.

6/19/20 → 6/18/24

Project: Other project

A Phase 1/2, Placebo-Controlled, Randomized, Observer-Blind, Dose Finding Study To Describe the Safety, Tolerability, Immunogenicity, and Potential Efficacy of SARS-CoV-2 RNA Vaccine Candidates against COVID 19 in Healthy Adults

6/19/20 → 6/18/24

Project: Other project

A Phase 1, Randomized, Single Dose, Blinded, Dose-Escalation Study to Assess Safety, Tolerability and Immunogenicity of ASP3772, a Pneumococcal Vaccine, in Toddlers 12 to 15 Months of Age in Comparison to an Active Comparator

6/19/20 → 6/18/23

Project: Other project

A Phase 1, Randomized, Single Dose, Blinded, Dose-Escalation Study to Assess Safety, Tolerability and Immunogenicity of ASP3772, a Pneumococcal Vaccine, in Toddlers 12 to 15 Months of Age in Comparison to an Active Comparator

Astellas Pharma Global Development Inc

6/19/20 → 6/18/23

Project: Other project

Cervicovaginal Vaccine Delivery by Novel Pod Intravaginal Rings for Therapeutic Immunization Against HSV-2

Milligan, G.

5/25/20 → 4/30/23

Project: Other project

A Phase 1b, Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Trial to Evaluate the Safety and Immunogenicity of mRNA-1653, a Combined Human Metapneumovirus (hMPV) and Parainfluenza Virus Type 3 (PIV3) Vaccine When Administered to Adults, and

2/12/20 → 2/11/25

Project: Other project

A Phase 1b, Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Trial to Evaluate the Safety and Immunogenicity of mRNA-1653, a Combined Human Metapneumovirus (hMPV) and Parainfluenza Virus Type 3 (PIV3) Vaccine When Administered to Adults, and

2/12/20 → 2/11/25

Project: Other project

A Phase 3, International, Multi-center, Randomized, Double-blind, Placebo- controlled Clinical Trial to Study the Efficacy, Immunogenicity, and Safety of the 9vHPV Vaccine, a Multivalent L1 Virus-like Particle Vaccine, in the prevention of oral persistencvbcvbcvbcvbcvbcvbcbcbcbcb

12/12/19 → 12/11/23

Project: Other project

A Phase 3, International, Multi-center, Randomized, Double-blind, Placebo- controlled Clinical Trial to Study the Efficacy, Immunogenicity, and Safety of the 9vHPV Vaccine, a Multivalent L1 Virus-like Particle Vaccine, in the prevention of oral persisten

12/12/19 → 12/11/23

Project: Other project

St. Vincent's Project

Raimer, B.

12/11/19 → 8/31/25

Project: Other project

A randomized, double blind, parallel-group, placebo controlled study to evaluate the efficacy and safety of IBP-9414 in premature infants 500-1500g birth weight in the prevention of necrotizing enterocolitis -The Connection study

Fonseca, R.

10/24/19 → 10/23/22

Project: Other project

A randomized, double blind, parallel-group, placebo controlled study to evaluate the efficacy and safety of IBP-9414 in premature infants 500-1500g birth weight in the prevention of necrotizing enterocolitis The Connection study

Fonseca, R.

10/24/19 → 10/23/22

Project: Other project

Supplement: Core B

8/1/19 → 6/30/23

Project: Other project

Supplement: RP2

8/1/19 → 6/30/23

Project: Other project

A Phase 3, Multicenter, Randomized, Double-blind, Active-Comparator-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of a 4 -dose Regimen of V114 in Healthy Infants (PNEU-PED)

4/25/19 → 4/24/23

Project: Other project

Modulation of the Allergenicity of Cedar and Ragweed Pollen Major Allergens

Midoro-Horiuti, T.

12/1/18 → 11/30/22

Project: Other project

Epithelial innate signaling in airway inflammation and remodeling

7/25/18 → 6/30/23

Project: Other project

Epithelial innate signaling in airway inflammation and remodeling

7/25/18 → 6/30/23

Project: Other project

Epithelial innate signaling in airway inflammation and remodeling

7/25/18 → 6/30/23

Project: Other project

Core B

7/25/18 → 6/30/23

Project: Other project

Epithelial innate signaling in airway inflammation and remodeling

7/25/18 → 6/30/23

Project: Other project

Epithelial innate signaling in airway inflammation and remodeling

7/25/18 → 6/30/23

Project: Other project

Admin Core

7/25/18 → 6/30/23

Project: Other project

SUBK-University of Wisconsin

7/25/18 → 6/30/23

Project: Other project

Epithelial innate signaling in airway inflammation and remodeling

7/25/18 → 6/30/23

Project: Other project

Epithelial innate signaling in airway inflammation and remodeling

7/25/18 → 6/30/23

Project: Other project

A PHASE 2, RANDOMIZED, OPEN-LABEL TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF A MULTIVALENT PNEUMOCOCCAL CONJUGATE VACCINE GIVEN WITH, OR SEPARATELY FROM, 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN HEALTHY INFANTS

7/5/18 → 7/4/23

Project: Other project

A Double-blind, Randomized, Placebo-controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MK-1654 in Pre-Term and Full-Term Infants

7/2/18 → 7/1/23

Project: Other project

A Phase 3, Multicenter, Randomized, Double-blind, Active Comparatorcontrolled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by Administration of PNEUMOVAX¿23 Six Months Later in Immunocompetent Adults Between 18 and 49 Y

7/1/18 → 6/30/23

Project: Other project

A Phase 3, Multicenter, Randomized, Double-blind, Active Comparator controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by Administration of PNEUMOVAX¿23 One Year Later in Healthy Adults 50 Years of Age or Older (PN

6/11/18 → 6/10/23

Project: Other project

A Phase III, partially modified double-blind, randomized, parallel-group, active-controlled, multi-center study to compare the immunogenicity and describe the safety of MenACYW conjugate vaccine and MENVEO® when administered concomitantly with routine pe

5/2/18 → 5/1/23

Project: Other project

Double-Blind, Randomized, Placebo-Controlled Phase 2b, Multi-center Study to Evaluate the Safety, Tolerability, Efficacy and Immunogenicity of a 2-Dose and a 3- Dose Regimen of V160 (Cytomegalovirus [CMV] Vaccine) in Healthy Seronegative Women, 16 to 35

4/24/18 → 4/23/23

Project: Other project

A PHASE 3, PLACEBO-CONTROLLED, RANDOMIZED, OBSERVER-BLINDEDS TUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER